Lipid Metabolism
0
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
NewAmsterdam PharmaObicetrapib
NewAmsterdam PharmaObicetrapib
Takedanormal dietary behavior
Clinical Trials (3)
Total enrollment: 431 patients across 3 trials
Randomized Study to Evaluate the Effect of Obicetrapib in Participants With Preclinical Alzheimer's Disease
Start: Sep 2026Est. completion: May 2029400 patients
Phase 2Not Yet Recruiting
Investigating the Effect of Obicetrapib on Lipoprotein Metabolism
Start: Dec 2023Est. completion: Oct 202422 patients
Phase 1Active Not Recruiting
Physiologic Plasticity of Intramyocardial Lipid Storage
Start: Jan 2010Est. completion: Dec 20119 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.